Tag: podcast

  • Children and COVID-19 Vaccines with William Muller, MD, PhD

    Children and COVID-19 Vaccines with William Muller, MD, PhD

    COVID-19 vaccines are being doled out across the nation, almost exclusively to adults. Pfizer’s vaccine has been authorized for ages 16 and up and Moderna’s vaccine for 18 and up. So when might younger children be vaccinated for COVID-19? And what needs to happen before then? William Muller, MD, PhD, offers insight.

  • A Promising Obesity Drug with Robert Kushner, MD

    A Promising Obesity Drug with Robert Kushner, MD

    The drug semaglutide, typically prescribed for treatment of Type 2 diabetes, was used in a phase 3 clinical trial as a treatment for obesity with very promising results. Northwestern’s Robert Kushner, MD, led this study published in the New England Journal of Medicine and shares the results.

  • Tracking COVID-19 Variants with Ramón Lorenzo-Redondo, PhD

    Tracking COVID-19 Variants with Ramón Lorenzo-Redondo, PhD

    Since SARS-CoV-2 was discovered in Illinois over a year ago, Feinberg scientists have been tracking the evolution of the disease in the Chicago area. Ramón Lorenzo Redondo, PhD, research assistant professor of Medicine in the Division of Infectious Diseases, is part of the team leading this work. He talks about the team’s research, the new…

  • COVID-19 and Vulnerable Communities with Mercedes Carnethon, PhD

    COVID-19 and Vulnerable Communities with Mercedes Carnethon, PhD

    Mercedes Carnethon, PhD, a Northwestern Medicine epidemiologist and population science expert, talks about how COVID-19 is affecting Black, Indigenous, Latinx and other people of color the most and what can be done to help these vulnerable communities as the pandemic continues and vaccine rollout lags behind.

  • Year in Review: How Feinberg Scientists Persevered in 2020 with Erin Spain, MS

    Year in Review: How Feinberg Scientists Persevered in 2020 with Erin Spain, MS

    Breakthroughs host Erin Spain takes a look back on the year 2020 and how Feinberg scientists responded to COVID-19 while publishing high-impact papers unrelated to the pandemic and making vital discoveries across the research enterprise during a difficult time.

  • How Lung Transplants Are Saving COVID-19 Patients with Ankit Bharat, MBBS

    How Lung Transplants Are Saving COVID-19 Patients with Ankit Bharat, MBBS

    Ankit Bharat, MBBS, Chief of Thoracic Surgery at Northwestern Medicine and director of the Lung Transplant program, shares findings that support why lung transplantation should be considered for patients who have developed irreversible lung disease due to COVID-19.

  • Can Exercise Slow Parkinson’s Disease Progression? with Daniel Corcos, PhD

    Can Exercise Slow Parkinson’s Disease Progression? with Daniel Corcos, PhD

    A $30 million dollar, phase 3 clinical trial at Northwestern is set to investigate whether exercise can slow Parkinson’s disease progression. Daniel Corcos, PhD, a professor of Physical Therapy and Human Movement Sciences, is leading the trial and explains what he hopes to accomplish.

  • Skilled Surgeons and Colon Cancer Survival with Karl Bilimoria, MD, and Brian Brajcich, MD

    Skilled Surgeons and Colon Cancer Survival with Karl Bilimoria, MD, and Brian Brajcich, MD

    Colon cancer is one of the most common cancers in the United States, with more than 100,000 new cases diagnosed every year. Surgery is often the primary treatment. A new Northwestern Medicine study shows patients whose surgery was performed by a highly skilled surgeon had a 70 percent lower risk of dying over five years…

  • How Amish People Informed a COVID-19 Clinical Trial with Douglas Vaughan, MD

    How Amish People Informed a COVID-19 Clinical Trial with Douglas Vaughan, MD

    A rare blood disorder related to people missing a protein, called PAI-1, was identified in a small Amish community. Douglas Vaughan, MD, studies the community and found that those without the protein seem to live longer and healthier lives. Now a PAI-1 inhibitor drug will be used for the first time in the U.S. in…

  • Influenza and COVID-19 with Michael Ison, MD, MS

    Influenza and COVID-19 with Michael Ison, MD, MS

    As flu season begins and COVID-19 continues to spread, Michael Ison, MD, is here to share some of his latest findings. He is part of Northwestern research teams running studies both on COVID-19 and on influenza vaccines and treatments.